2 studies found for:    15279717 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory Central Nervous System (CNS) Lymphoma
Condition: B-Cell Lymphoma Originating in the CNS
Intervention: Drug: Temozolomide
2 Withdrawn Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Condition: Soft Tissue Sarcomas
Interventions: Drug: Chemoradiotherapy Temozolomide;   Radiation: Proton therapy;   Procedure: Proton Chemoradiotherapy followed by surgery

Indicates status has not been verified in more than two years